A carregar...

Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis

The purpose of this study is to investigate whether the Y402H polymorphism (rs1061170, a T-to-C transition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics effect on the anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Chen, Guohai, Tzekov, Radouil, Li, Wensheng, Jiang, Fangzheng, Mao, Sihong, Tong, Yuhua
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4585967/
https://ncbi.nlm.nih.gov/pubmed/26411831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep14517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!